Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0346 Transporter Info
Gene Name	SLC39A5
Transporter Name	Zinc transporter ZIP5
Gene ID	283375
UniProt ID	Q6ZMH5

Post-Translational Modification of This DT
Overview of SLC39A5 Modification Sites with Functional and Structural Information
Sequence	M M G S P V S H L L A G F C V W V V L G W V G G S V P N L G P A E Q E Q N H Y L A Q L F G L Y G E N G T L T A G G L A R L L H S L G L G R V Q G L R L G Q H G P L T G R A A S P A A D N S T H R P Q N P E L S V D V W A G M P L G P S G W G D L E E S K A P H L P R G P A P S G L D L L H R L L L L D H S L A D H L N E D C L N G S Q L L V N F G L S P A A P L T P R Q F A L L C P A L L Y Q I D S R V C I G A P A P A P P G D L L S A L L Q S A L A V L L L S L P S P L S L L L L R L L G P R L L R P L L G F L G A L A V G T L C G D A L L H L L P H A Q E G R H A G P G G L P E K D L G P G L S V L G G L F L L F V L E N M L G L L R H R G L R P R C C R R K R R N L E T R N L D P E N G S G M A L Q P L Q A A P E P G A Q G Q R E K N S Q H P P A L A P P G H Q G H S H G H Q G G T D I T W M V L L G D G L H N L T D G L A I G A A F S D G F S S G L S T T L A V F C H E L P H E L G D F A M L L Q S G L S F R R L L L L S L V S G A L G L G G A V L G V G L S L G P V P L T P W V F G V T A G V F L Y V A L V D M L P A L L R P P E P L P T P H V L L Q G L G L L L G G G L M L A I T L L E E R L L P V T T E G
PTM type	X-Methylation X-N-glycosylation X-O-glycosylation X-Phosphorylation X: Amino Acid

Methylation
Histidine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC39A5			[1]
Role of PTM	Potential impacts
Modified Residue	Histidine	Modified Location	375
Related Enzyme	Protein-L-histidine N-pros-methyltransferase (METTL9)
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at SLC39A5 Histidine 375 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC39A5			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	50
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC39A5 Asparagine 50 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC39A5			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	160
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC39A5 Asparagine 160 has the potential to affect its expression or activity.
O-glycosylation
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC39A5			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	135
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC39A5 Serine 135 has the potential to affect its expression or activity.
Phosphorylation
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC39A5			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	336
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A5 Serine 336 has the potential to affect its expression or activity.
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC39A5			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	177
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A5 Threonine 177 has the potential to affect its expression or activity.

References
1	The methyltransferase METTL9 mediates pervasive 1-methylhistidine modification in mammalian proteomes. Nat Commun. 2021 Feb 9;12(1):891.
2	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S39A5_HUMAN)
3	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
4	Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab. Neoplasia. 2018 Jul;20(7):668-677.
5	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
6	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence